Curt I. Civin

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Venetoclax and pegcrisantaspase for complex karyotype acute myeloid leukemia”.

Venetoclax and pegcrisantaspase for complex karyotype acute myeloid leukemia

Leukemia(2020)10.1038/s41375-020-01080-6

N/A

0DataRank · unranked

36 citations

Bandish Kapadia, Dominique Bollino, Binny Bhandary, Maria R. Baer, Sandrine Niyongere +15 more

Hypoxia-inducible factor 1-alpha enhances the secretome to rejuvenate adult cardiosphere-derived cells

Journal of Thoracic and Cardiovascular Surgery(2021)10.1016/j.jtcvs.2021.07.015

N/A

0DataRank · unranked

6 citations

Min-Jung Kim, Antariksh Tulshyan, Yin Guo, Rachana Mishra, Deqiang Li +4 more

Comparative efficacy and mechanism of action of cardiac progenitor cells after cardiac injury

iScience(2022)10.1016/j.isci.2022.104656

N/A

0DataRank · unranked

14 citations

Rachana Mishra, Progyaparamita Saha, David L.S. Morales, Wen‐Chih Cheng, Arun Jayaraman +17 more

A Novel 2-Carbon-Linked Dimeric Artemisinin With Potent Antileukemic Activity and Favorable Pharmacology

Frontiers in Oncology(2022)10.3389/fonc.2021.790037

N/A

0DataRank · unranked

6 citations

Blake S. Moses, Bryan T. Mott, Ganesha Rai, Nicole M. Anders, Michelle A. Rudek +2 more

ART714 is a best-in-class antileukemic 2-carbon-linked dimeric artemisinin derivative

Cancer Chemotherapy and Pharmacology(2023)10.1007/s00280-023-04539-2

N/A

0DataRank · unranked

0 citations

Blake S. Moses, Rena G. Lapidus, Bryan T. Mott, Ganesha Rai, Nicole M. Anders +4 more

The polypharmacy combination of the BCL-2 inhibitor venetoclax (VEN) and the FLT3 inhibitor gilteritinib (GIL) is more active in acute myeloid leukemia cells than novel polypharmacologic BCL-2/FLT3 VEN–GIL hybrid single-molecule inhibitors

European Journal of Medicinal Chemistry(2024)10.1016/j.ejmech.2024.117190

N/A

0DataRank · unranked

7 citations

Christian Eberly, Alexandria M. Chan, Minjung Kim, Brandon D. Lowe, Curt I. Civin +2 more

Augmenting the Anti‐Leukemic Activity of the BCL‐2 Inhibitor Venetoclax Through Its Transformation Into Polypharmacologic Dual BCL‐2/HDAC1 and Dual BCL‐2/HDAC6 Inhibitors

Drug Development Research(2025)10.1002/ddr.70084

N/A

0DataRank · unranked

5 citations

Christian Eberly, Brandon Drennen, Christopher C. Goodis, Zoe Wuyts, Curt I. Civin +2 more